Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.
3.

Systems Biology Approaches and Applications in Obesity, Diabetes, and Cardiovascular Diseases.

Meng Q, Mäkinen VP, Luk H, Yang X.

Curr Cardiovasc Risk Rep. 2013 Feb;7(1):73-83. Epub 2012 Oct 18.

4.

Endothelin and endothelin receptors in the renal and cardiovascular systems.

Vignon-Zellweger N, Heiden S, Miyauchi T, Emoto N.

Life Sci. 2012 Oct 15;91(13-14):490-500. doi: 10.1016/j.lfs.2012.03.026. Epub 2012 Mar 28. Review.

5.

Effects of bedrest 1: cardiovascular, respiratory and haematological systems.

Knight J, Nigam Y, Jones A.

Nurs Times. 2009 Jun 2-8;105(21):16-20. Review.

PMID:
19548502
6.

Toxic effects of mercury on the cardiovascular and central nervous systems.

Fernandes Azevedo B, Barros Furieri L, Peçanha FM, Wiggers GA, Frizera Vassallo P, Ronacher Simões M, Fiorim J, Rossi de Batista P, Fioresi M, Rossoni L, Stefanon I, Alonso MJ, Salaices M, Valentim Vassallo D.

J Biomed Biotechnol. 2012;2012:949048. doi: 10.1155/2012/949048. Epub 2012 Jul 2. Review.

7.

Toxicology of smokeless tobacco: implications for immune, reproductive, and cardiovascular systems.

Willis D, Popovech M, Gany F, Zelikoff J.

J Toxicol Environ Health B Crit Rev. 2012;15(5):317-31. doi: 10.1080/10937404.2012.689553. Review.

PMID:
22852812
8.

Systems-based approaches to cardiovascular disease.

MacLellan WR, Wang Y, Lusis AJ.

Nat Rev Cardiol. 2012 Jan 10;9(3):172-84. doi: 10.1038/nrcardio.2011.208. Review.

9.

Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques.

Zannad F, De Backer G, Graham I, Lorenz M, Mancia G, Morrow DA, Reiner Z, Koenig W, Dallongeville J, Macfadyen RJ, Ruilope LM, Wilhelmsen L; ESC Working Group on CardioVascular Pharmacology and Drug Therapy.

Fundam Clin Pharmacol. 2012 Apr;26(2):163-74. doi: 10.1111/j.1472-8206.2011.01023.x. Epub 2012 Jan 5. Review.

PMID:
22220636
10.

Electrode systems for continuous monitoring in cardiovascular surgery.

CLARK LC Jr, LYONS C.

Ann N Y Acad Sci. 1962 Oct 31;102:29-45. No abstract available.

PMID:
14021529
11.

Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems.

Song P, Zou MH.

Free Radic Biol Med. 2012 May 1;52(9):1607-19. doi: 10.1016/j.freeradbiomed.2012.01.025. Epub 2012 Feb 4. Review.

12.

Acute effects of dokha smoking on the cardiovascular and respiratory systems among UAE male university students.

Shaikh RB, Abdul Haque NM, Abdul Hadi Khalil Al Mohsen H, Abdul Hadi Khalil Al Mohsen A, Haitham Khalaf Humadi M, Zaki Al Mubarak Z, Mathew E, Al Sharbatti S.

Asian Pac J Cancer Prev. 2012;13(5):1819-22.

13.

Imaging interactions between the immune and cardiovascular systems in vivo by multiphoton microscopy.

Millington OR, Brewer JM, Garside P, Maffia P.

Methods Mol Biol. 2010;616:193-206. doi: 10.1007/978-1-60761-461-6_13.

PMID:
20379877
14.
15.
16.

Systems biology approaches and pathway tools for investigating cardiovascular disease.

Wheelock CE, Wheelock AM, Kawashima S, Diez D, Kanehisa M, van Erk M, Kleemann R, Haeggström JZ, Goto S.

Mol Biosyst. 2009 Jun;5(6):588-602. doi: 10.1039/b902356a. Epub 2009 Apr 27. Review.

PMID:
19462016
17.
18.

Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.

Palm F, Onozato ML, Luo Z, Wilcox CS.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3227-45. Epub 2007 Oct 12. Review.

19.

Non-analgesic effects of opioids: cardiovascular effects of opioids and their receptor systems.

Headrick JP, Pepe S, Peart JN.

Curr Pharm Des. 2012;18(37):6090-100.

PMID:
22747541

Supplemental Content

Support Center